Dasatinib 50 mg Tablet

Spnib 50 Mg Tablet : Uses, Dosage, Side Effects, Precautions and Storage

What is Spnib 50 Mg Tablet?​

Spnib 50 Mg, Dasatinib is the active ingredient in the tablet. This medication is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase, as well as Ph+ acute lymphoblastic leukemia in patients who have not responded to other treatments.

How Spnib 50 Mg Works?

Spnib 50 Mg Tablet works by binding to both active and inactive sites on the BCR ABL tyrosine kinase enzyme. It reduces and inhibits the uncontrolled production of white blood cells.

How to take Spnib 50 Mg Tablet?

You must take Spnib Dasatinib 50 mg exactly as directed by your physician. Take the tablet at the same time every day, with or without food.

Spnib 50 Mg Tablet Side Effects

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain,
• weakness
• Low appetite
• High or low BP

Warning & Precautions

• This tablet may be harmful to an unborn child. If you are pregnant or suspect you may be pregnant, notify your doctor before beginning this treatment.
• Before breastfeeding while on this treatment, consult with your doctor. During this course of treatment, your doctor may advise you to discontinue breastfeeding.
• If you have liver disease, consult your doctor before beginning this treatment. Your doctor will prescribe the appropriate dosage.
• If you have kidney disease, consult your doctor before beginning this treatment. Your doctor will prescribe the appropriate dosage.
• If you have symptoms such as shortness of breath or altered consciousness, avoid driving or operating machinery.
• This medication has the potential to cause an abnormal heart rate, heart problems, or a heart attack. Your doctor will check your potassium and magnesium levels as well as your heart function.
• Inform your doctor if you have any allergic reactions to Dasatinib 50 mg or any of its ingredients.
• If you have immune system issues, notify your doctor before beginning this treatment.
• This medication may cause a significant decrease in the number of platelets, WBC, or RBC in the blood. Ensure that your blood levels are checked at regular intervals by your doctor.
• Inform your doctor if you are lactose intolerant, have low potassium or magnesium levels in your blood, or if your immune system is compromised.

How to store Spnib 50 Mg Tablet?

• Spnib 50 Mg should be stored at room temperature .
• Keep the container well closed, dry, and out of children’s reach.
• Sore it in a cool, dry place, away from sunlight and moisture.

All Substitutes

Spnib 50 Mg Tablet

View All Substitutes >>

Buy Spnib 50 mg Online at Best Price From India

Drugssquare is an authorized supplier, exporter and retailer of Spnib Dasatinib 50 mg Tablets in Philippines, China, Australia, Nigeria, Thailand, Cambodia, United Arab Emirates (UAE), Peru, Vietnam, South Africa, Hong Kong, South Korea, Japan, Egypt, Chile, Malaysia, Ecuador, Indonesia and other countries. We put patients first. If you want to purchase low-cost Zydus Spnib 50mg tablet, place an order online with us today and we will deliver it directly to your door. Our specialty pharmacy strives to improve the lives of patients with leukemia by providing generic blood cancer medicines with huge discounts and special offers.

Medical Disclaimer

In order to legally purchase this medicine from DrugsSquare, you’ll require a prescription from your Registered Medical Practitioner.

Note:

All content found on Drugssquare.com, including text, images, or other formats, is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always consult your doctor or other qualified health professionals if you have any questions regarding your health, medicine, or medical condition. This pharmacy is present to deliver, supply, export, or dispense prescription and OTC medicines online directly to consumers/patients.